Profil
Karl-Heinz Krause is the founder.
Dr. Krause is the founder of Calliditas Therapeutics Suisse SA, founded in 2006, holding the title of Director.
Dr. Krause is also the founder of Azurecell Therapies.
Current jobs include being a Member at the American Society for Clinical Investigation and a Member at the Swiss Academy of Medical Sciences.
Education history includes a doctorate from Ludwig-Maximilians-Universität München, conferred in 1982.
Postes actifs de Karl-Heinz Krause
| Sociétés | Poste | Début |
|---|---|---|
Swiss Academy of Medical Sciences | Corporate Officer/Principal | - |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Corporate Officer/Principal | - |
Anciens postes connus de Karl-Heinz Krause
| Sociétés | Poste | Fin |
|---|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Fondateur | - |
Formation de Karl-Heinz Krause
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Health Technology |
Swiss Academy of Medical Sciences |
















